Avalo Therapeutics Inc
AVTX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$384.53M
Close$
$0.99
86.4% downside
Current Fair Value
86.4% downsideOvervalued by 86.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $384.53 Million |
|---|---|
| Enterprise Value | $299.15 Million |
| Earnings per Share | $-5.84 |
| Beta | 0.79 |
| Outstanding Shares | 43,602,044 |
Return
| Return on Equity | -22.36% |
|---|---|
| Return on Assets | -20.44% |
| Return on Invested Capital | -20.48% |
Valuation & Multiples
| P/E Ratio | -1.51 |
|---|---|
| PEG | -2.01 |
| Price to Sales | - |
| Price to Book Ratio | 0.73 |
| Enterprise Value to Revenue | 5070.25 |
| Enterprise Value to EBIT | -3.11 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.58
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.59
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 80.00% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.24%▼ 162.35% |
|---|---|
| Total Invested | $1.59M▼ 99.88% |
| Investors Holding | 16▼ 120.00% |
About Avalo Therapeutics Inc
31 employees
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases. The company is advancing its clinical-stage pipeline of innovative therapies that ad...